Download Files:
CGP-35949 (sodium)
$315
Only 1000 item(s) left in stock.
Products Details
Product Description
– CGP-35949 sodium is a LTD4 antagonist with phospholipase inhibitory activity. CGP-35949 sodium can be used for research of asthma[1].
Web ID
– HY-19041
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C23H25ClN5NaO5
References
– [1]Beck A, et al. CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma. Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:771-4.
CAS Number
– 111130-13-3
Molecular Weight
– 509.92
SMILES
– ClC1=CC(C)=C(NC(C2=NN=N[N-]2)=O)C=C1OCCCOC3=CC=C(C(C)=O)C(O)=C3CCC.[Na+]
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– Leukotriene Receptor;Phospholipase
Pathway
– GPCR/G Protein;Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
